# Clinical Study on the Efficacy and Safety of Nalfurafine Hydrochloride Orally Disintegrating Tablets in Treating Pruritus in Patients Undergoing Maintenance Hemodialysis

> **NCT07650851** · NA · NOT_YET_RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Chronic Kidney Disease-Associated Pruritus in Hemodialysis

## Interventions

- **DRUG:** Nalfurafine Hydrochloride
- **OTHER:** Basic treatment

## Key facts

- **NCT ID:** NCT07650851
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-06-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07650851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07650851, "Clinical Study on the Efficacy and Safety of Nalfurafine Hydrochloride Orally Disintegrating Tablets in Treating Pruritus in Patients Undergoing Maintenance Hemodialysis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07650851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*